Summary of Study ST002003
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001269. The data can be accessed directly via it's Project DOI: 10.21228/M8PD9N This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002003 |
| Study Title | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) |
| Study Summary | Targeted and untargeted metabolomics analysis consisting of 888 metabolic analytes covering primary metabolites, biogenic amines, complex lipids, and oxylipins in 106 ME/CFS cases and 91 frequency-matched healthy controls |
| Institute | Columbia University |
| Department | Center for Infection and Immunity |
| Laboratory | Center for Infection and Immunity |
| Last Name | Lipkin |
| First Name | W. Ian |
| Address | 722 W. 168th St., 17th Floor, New York, NY, 10032 |
| wil2001@cumc.columbia.edu | |
| Phone | 212-342-9033 |
| Submit Date | 2021-11-23 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | wiff |
| Analysis Type Detail | LC-MS |
| Release Date | 2021-12-08 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR001269 |
| Project DOI: | doi: 10.21228/M8PD9N |
| Project Title: | Case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) |
| Project Summary: | Targeted and untargeted metabolomics analysis consisting of 888 metabolic analytes covering primary metabolites, biogenic amines, complex lipids, and oxylipins in 106 ME/CFS cases and 91 frequency-matched healthy controls. |
| Institute: | Columbia University |
| Department: | Center for Infection and Immunity |
| Last Name: | Lipkin |
| First Name: | W. Ian |
| Address: | 722 W. 168th St., 17th Floor, New York, NY, 10032 |
| Email: | wil2001@cumc.columbia.edu |
| Phone: | 212-342-9033 |
| Funding Source: | This study was funded by National Institutes of Health U54 AI138370 (Center for Solutions for ME/CFS) |
Subject:
| Subject ID: | SU002084 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | local_sample_id | treatment |
|---|---|---|
| SA187419 | GH025_157 | case |
| SA187420 | GH024_156 | case |
| SA187421 | CD067_084 | case |
| SA187422 | CD064_082 | case |
| SA187423 | CD065_083 | case |
| SA187424 | CD073_089 | case |
| SA187425 | CD074_090 | case |
| SA187426 | GH019_153 | case |
| SA187427 | GH017_152 | case |
| SA187428 | GH021_154 | case |
| SA187429 | GH022_155 | case |
| SA187430 | CD075_091 | case |
| SA187431 | CD076_092 | case |
| SA187432 | CD063_081 | case |
| SA187433 | CD059_079 | case |
| SA187434 | CD039_064 | case |
| SA187435 | GH053_170 | case |
| SA187436 | GH054_171 | case |
| SA187437 | CD035_061 | case |
| SA187438 | GH058_173 | case |
| SA187439 | CD041_066 | case |
| SA187440 | GH049_168 | case |
| SA187441 | CD055_077 | case |
| SA187442 | GH037_161 | case |
| SA187443 | CD053_076 | case |
| SA187444 | GH040_164 | case |
| SA187445 | GH042_166 | case |
| SA187446 | CD083_097 | case |
| SA187447 | AB003_001 | case |
| SA187448 | EF031_123 | case |
| SA187449 | EF032_124 | case |
| SA187450 | EF029_122 | case |
| SA187451 | EF028_121 | case |
| SA187452 | EF024_118 | case |
| SA187453 | EF026_119 | case |
| SA187454 | EF033_125 | case |
| SA187455 | EF034_126 | case |
| SA187456 | EF043_131 | case |
| SA187457 | GH002-2_142 | case |
| SA187458 | EF041_130 | case |
| SA187459 | GH004_143 | case |
| SA187460 | EF035_127 | case |
| SA187461 | EF023_117 | case |
| SA187462 | EF020_116 | case |
| SA187463 | EF004_105 | case |
| SA187464 | EF005_106 | case |
| SA187465 | EF003_104 | case |
| SA187466 | EF001_102 | case |
| SA187467 | GH060_174 | case |
| SA187468 | GH008_146 | case |
| SA187469 | EF010_110 | case |
| SA187470 | EF017_114 | case |
| SA187471 | EF019_115 | case |
| SA187472 | EF013_113 | case |
| SA187473 | EF012_112 | case |
| SA187474 | EF011_111 | case |
| SA187475 | CD084_098 | case |
| SA187476 | CD043_068 | case |
| SA187477 | IJ043_189 | case |
| SA187478 | AB047_026 | case |
| SA187479 | IJ044_190 | case |
| SA187480 | IJ046_191 | case |
| SA187481 | AB037_020 | case |
| SA187482 | IJ047_192 | case |
| SA187483 | AB049_027 | case |
| SA187484 | AB050_028 | case |
| SA187485 | IJ013_184 | case |
| SA187486 | IJ009_182 | case |
| SA187487 | IJ014_185 | case |
| SA187488 | AB055_031 | case |
| SA187489 | IJ030_187 | case |
| SA187490 | CD030_058 | case |
| SA187491 | AB036_019 | case |
| SA187492 | AB034_018 | case |
| SA187493 | AB010_006 | case |
| SA187494 | AB012_007 | case |
| SA187495 | AB009-2_005 | case |
| SA187496 | AB008_004 | case |
| SA187497 | AB004_002 | case |
| SA187498 | AB006_003 | case |
| SA187499 | AB014_008 | case |
| SA187500 | AB017_009 | case |
| SA187501 | IJ052_194 | case |
| SA187502 | IJ049_193 | case |
| SA187503 | IJ059_195 | case |
| SA187504 | AB023_011 | case |
| SA187505 | AB022_010 | case |
| SA187506 | IJ006_181 | case |
| SA187507 | AB052_030 | case |
| SA187508 | CD016_048 | case |
| SA187509 | CD015_047 | case |
| SA187510 | CD014_046 | case |
| SA187511 | IJ001_178 | case |
| SA187512 | CD001-2_038 | case |
| SA187513 | CD019-2_050 | case |
| SA187514 | CD027_056 | case |
| SA187515 | CD024_053 | case |
| SA187516 | CD022_052 | case |
| SA187517 | CD020_051 | case |
| SA187518 | CD011_044 | case |
Collection:
| Collection ID: | CO002077 |
| Collection Summary: | Plasma was collected from case and control patients |
| Sample Type: | Blood (plasma) |
Treatment:
| Treatment ID: | TR002096 |
| Treatment Summary: | Case versus control |
Sample Preparation:
| Sampleprep ID: | SP002090 |
| Sampleprep Summary: | Extraction is carried out using a bi-phasic solvent system of cold methanol, methyl tert-butyl ether (MTBE), and water. In more detail, cold methanol (225 µL is added to a 5mg tissue sample aliquot, which is placed into a 1.5 mL Eppendorf tube. Then, 750 µL of cold MTBE is added, followed by vortexing for 10 s. and shaking for 6 min. at 4ºC. Phase separation is induced by adding 188 µL of mass spec-grade water. After vortexing for 20 s. the sample is centrifuged at 14,000 rpm for 2 min. The upper organic phase is collected in two 300 µL aliquots for lipid analysis polar layer is collected in two 125 µL aliquots for HILIC analysis. One is stored at -20ºC as a backup and the other is evaporated to dryness in a SpeedVac. Dried extracts are resuspended in acetonitrile. |
Chromatography:
| Chromatography ID: | CH002410 |
| Chromatography Summary: | The LC/QTOFMS analyses are performed using an Agilent 1290 Infinity LC system (G4220A binary pump, G4226A autosampler, and G1316C Column Thermostat) coupled to a SCIEX Triple TOF mass spectrometer. Polar compounds are separated on an Acquity UPLC BEH Amide Column, 130Å, 1.7 µm, 2.1 mm X 150 mm maintained at 45°C at a flow-rate of 0.4 mL/min. Solvent pre-heating (Agilent G1316) was used. The mobile phases consist of: Water, 10 mM Ammonium Formate, 0.125% Formic Acid (A) and Acetonitrile: Water (95/5, v/v), 10 mM Ammonium Formate, 0.125% Formic Acid (B) |
| Instrument Name: | Agilent 6600 |
| Column Name: | Waters Acquity UPLC BEH amide,(150 x 2.1mm,1.7um) |
| Column Temperature: | 45 |
| Flow Rate: | 0.4 mL/min |
| Solvent A: | 100% water; 0.125% formic acid; 10 mM ammonium formate |
| Solvent B: | 95% acetonitrile/5% water; 0.125% formic acid; 10 mM ammonium formate |
| Chromatography Type: | HILIC |
Analysis:
| Analysis ID: | AN003266 |
| Analysis Type: | MS |
| Chromatography ID: | CH002410 |
| Num Factors: | 2 |
| Num Metabolites: | 237 |
| Rt Units: | Minutes |
| Units: | normalized peak height |